Holocene Advisors, LP Exact Sciences Corp Transaction History
Holocene Advisors, LP
- $38 Billion
- Q2 2025
A detailed history of Holocene Advisors, LP transactions in Exact Sciences Corp stock. As of the latest transaction made, Holocene Advisors, LP holds 2,145,181 shares of EXAS stock, worth $119 Million. This represents 0.3% of its overall portfolio holdings.
Number of Shares
2,145,181
Previous 741,095
189.46%
Holding current value
$119 Million
Previous $32.1 Million
255.32%
% of portfolio
0.3%
Previous 0.1%
Shares
9 transactions
Others Institutions Holding EXAS
# of Institutions
651Shares Held
157MCall Options Held
1.43MPut Options Held
2.3M-
Capital World Investors Los Angeles, CA18.2MShares$1.01 Billion0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.9MShares$992 Million0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$669 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12MShares$665 Million0.12% of portfolio
-
State Street Corp Boston, MA5.38MShares$298 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.81B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...